Cuschieri A; EUROCAT Working Group Anorectal anomalies associated with or as part of other anomalies. Am J Med Genet. 2002 Jun 15;110(2):122-30.
Cuschieri A; EUROCAT Working Group Descriptive epidemiology of isolated anal anomalies: a survey of 4.6 million births in Europe. Am J Med Genet. 2001 Oct 15;103(3):207-15.
Jenetzky E Prevalence estimation of anorectal malformations using German diagnosis related groups system. Pediatr Surg Int. 2007 Dec;23(12):1161-5.
Jones MP, Post J, Crowell MD High-resolution manometry in the evaluation of anorectal disorders: a simultaneous comparison with water-perfused manometry. Am J Gastroenterol. 2007 Apr;102(4):850-5.
Jorge JM, Wexner SD Etiology and management of fecal incontinence. Dis Colon Rectum. 1993 Jan;36(1):77-97. Review.
Keshtgar AS, Athanasakos E, Clayden GS, Ward HC Evaluation of outcome of anorectal anomaly in childhood: the role of anorectal manometry and endosonography. Pediatr Surg Int. 2008 Aug;24(8):885-92. doi: 10.1007/s00383-008-2181-1. Epub 2008 May 30.
Levitt MA, Kant A, Peña A The morbidity of constipation in patients with anorectal malformations. J Pediatr Surg. 2010 Jun;45(6):1228-33. doi: 10.1016/j.jpedsurg.2010.02.096.
Levitt MA, Peña A Outcomes from the correction of anorectal malformations. Curr Opin Pediatr. 2005 Jun;17(3):394-401.
Levitt MA, Soffer SZ, Peña A Continent appendicostomy in the bowel management of fecally incontinent children. J Pediatr Surg. 1997 Nov;32(11):1630-3.
Lowry RB, Sibbald B, Bedard T Stability of prevalence rates of anorectal malformations in the Alberta Congenital Anomalies Surveillance System 1990-2004. J Pediatr Surg. 2007 Aug;42(8):1417-21.
Marcelis C, de Blaauw I, Brunner H Chromosomal anomalies in the etiology of anorectal malformations: a review. Am J Med Genet A. 2011 Nov;155A(11):2692-704. doi: 10.1002/ajmg.a.34253. Epub 2011 Oct 11. Review.
Obel C, Dalsgaard S, Stax HP, Bilenberg N [Strengths and Difficulties Questionnaire (SDQ-Dan). A new instrument for psychopathologic screening of children aged 4-16 years]. Ugeskr Laeger. 2003 Jan 27;165(5):462-5. Danish.
Peña A, Devries PA Posterior sagittal anorectoplasty: important technical considerations and new applications. J Pediatr Surg. 1982 Dec;17(6):796-811.
Peña A, Hong A Advances in the management of anorectal malformations. Am J Surg. 2000 Nov;180(5):370-6. Review.
Poley MJ, Stolk EA, Tibboel D, Molenaar JC, Busschbach JJ Short term and long term health related quality of life after congenital anorectal malformations and congenital diaphragmatic hernia. Arch Dis Child. 2004 Sep;89(9):836-41.
Rangel SJ, Lawal TA, Bischoff A, Chatoorgoon K, Louden E, Peña A, Levitt MA The appendix as a conduit for antegrade continence enemas in patients with anorectal malformations: lessons learned from 163 cases treated over 18 years. J Pediatr Surg. 2011 Jun;46(6):1236-42. doi: 10.1016/j.jpedsurg.2011.03.060.
Wittrup-Jensen KU, Lauridsen JT, Gudex C et al Estimating Danish EQ-5D tariffs using TTO and VAS. In: Norinder A, Pedersen K, Roos P, editors. Proceedings of the 18th Plenary Meeting of the EuroQol Group. IHE, The Swedish Institute for Health Economics 2002; 257-292.
Witvliet MJ, Slaar A, Heij HA, van der Steeg AF Qualitative analysis of studies concerning quality of life in children and adults with anorectal malformations. J Pediatr Surg. 2013 Feb;48(2):372-9. doi: 10.1016/j.jpedsurg.2012.11.018. Review.
Yong C, Ruo-yi W, Yuan Z, Shu-hui Z, Guang-Rui S MRI findings in patients with defecatory dysfunction after surgical correction of anorectal malformation. Pediatr Radiol. 2013 Aug;43(8):964-70. doi: 10.1007/s00247-013-2639-8. Epub 2013 Mar 7.
Zwink N, Jenetzky E, Brenner H Parental risk factors and anorectal malformations: systematic review and meta-analysis. Orphanet J Rare Dis. 2011 May 17;6:25. doi: 10.1186/1750-1172-6-25. Review.
Long-term Outcome in Patients Operated for Congenital Anorectal Malformations
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.